CD44 and neoplasm: The photoimmunotheranostic effects against CD44‐expressing TNBC tumors have previously been reported using xenograft orthotopic TNBC murine models, whereby the putative therapy was able to selectively destroy CD44‐expressing tumors, thus enhancing tumor‐free survival [8, 65, 291].